Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership51,945 shares
Latest Disclosed Value $ 182,327
Prudential Financial Inc reports 194.06% increase in ownership of IOVA / Iovance Biotherapeutics, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 51,945 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $182,327 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 17,665 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 194.06% during the quarter. The current value of the position is $227,519 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 51,945 34,280 194.06 182 279.17 0.0001
2026-02-13 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 17,665 -17,165 -49.28 48 -36.00 0.0001
2025-11-13 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 34,830 0 0.00 76 -57.63 0.0001
2025-08-12 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 34,830 14,440 70.82 177 110.71 0.0002
2025-05-13 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 20,390 -11,310 -35.68 84 -64.10 0.0001
2025-02-11 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 31,700 14,452 83.79 235 45.34 0.0003
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 17,248 -54,162 -75.85 162 -71.85 0.0002
2024-08-13 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 71,410 -4,153 -5.50 573 -48.88 0.0009
2024-05-14 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 75,563 60,668 407.30 1,120 824.79 0.0016
2024-02-13 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 14,895 704 4.96 121 89.06 0.0002
2023-11-13 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 14,191 974 7.37 65 -31.18 0.0001
2023-08-11 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,217 2,906 28.18 93 47.62 0.0001
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 10,311 -247 -2.34 63 -5.97 0.0001
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 10,558 214 2.07 67 -32.32 0.0001
2022-11-04 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 10,344 -1,019 -8.97 99 -19.51 0.0002
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 11,363 11,363 123 0.0002
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -39,945 -100.00 0 -100.00
2021-08-16 2020-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 0046 462260100 39,945 39,945 1,854 0.0031
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 39,945 39,945 1,854 0.0031
2020-08-12 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -224 -100.00 0 -100.00
2021-08-05 2020-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 0029 462260100 224 -8,148 -97.32 7 -96.98 0.0018
2020-05-12 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 7,490 -882 224 0.0005
2020-02-11 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,372 8,372 232 0.0003
2019-11-13 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -8,640 -100.00 0 -100.00
2019-08-08 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,640 8,640 212 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.